共 33 条
3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism
被引:173
作者:

Huang, CK
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China

Wei, P
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China

Fan, KQ
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China

Liu, Y
论文数: 0 引用数: 0
h-index: 0
机构: Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China

Lai, LH
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China
机构:
[1] Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Coll Chem & Mol Engn, Beijing 100871, Peoples R China
[2] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China
关键词:
D O I:
10.1021/bi036022q
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
SARS 3C-like proteinase has been proposed to be a key enzyme for drug design against SARS. Lack of a suitable assay has been a major hindrance for enzyme kinetic studies and a large-scale inhibitor screen for SARS 3CL proteinase. Since SARS 3CL proteinase belongs to the cysteine protease family (family C3 in clan CB) with a chymotrypsin fold, it is important to understand the catalytic mechanism of SARS 3CL proteinase to determine whether the proteolysis proceeds through a general base catalysis mechanism like chymotrypsin or an ion pair mechanism like papain. We have established a continuous colorimetric assay for SARS 3CL proteinase and applied it to study the enzyme catalytic mechanism. The proposed catalytic residues His41 and Cys145 were confirmed to be critical for catalysis by mutating to Ala, while the Cys145 to Set mutation resulted in an active enzyme with a 40-fold lower activity. From the pH dependency of catalytic activity, the pK(a)'s for His41 and Cys145 in the wild-type enzyme were estimated to be 6.38 and 8.34, while the pK(a)'s for His41 and Ser145 in the C145S mutant were estimated to be 6.15 and 9.09, respectively. The C145S mutant has a normal isotope effect in D2O for general base catalysis, that is, reacts slower in D2O, while the wild-type enzyme shows an inverse isotope effect which may come from the lower activation enthalpy. The pK(a) values measured for the active site residues and the activity of the C145S mutant are consistent with a general base catalysis mechanism and cannot be explained by a thiolate-imidazolium ion pair model.
引用
收藏
页码:4568 / 4574
页数:7
相关论文
共 33 条
[1]
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
[J].
Anand, K
;
Ziebuhr, J
;
Wadhwani, P
;
Mesters, JR
;
Hilgenfeld, R
.
SCIENCE,
2003, 300 (5626)
:1763-1767

Anand, K
论文数: 0 引用数: 0
h-index: 0
机构: Univ Lubeck, Inst Biochem, D-23538 Lubeck, Germany

Ziebuhr, J
论文数: 0 引用数: 0
h-index: 0
机构: Univ Lubeck, Inst Biochem, D-23538 Lubeck, Germany

Wadhwani, P
论文数: 0 引用数: 0
h-index: 0
机构: Univ Lubeck, Inst Biochem, D-23538 Lubeck, Germany

Mesters, JR
论文数: 0 引用数: 0
h-index: 0
机构: Univ Lubeck, Inst Biochem, D-23538 Lubeck, Germany

Hilgenfeld, R
论文数: 0 引用数: 0
h-index: 0
机构: Univ Lubeck, Inst Biochem, D-23538 Lubeck, Germany
[2]
Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain
[J].
Anand, K
;
Palm, GJ
;
Mesters, JR
;
Siddell, SG
;
Ziebuhr, J
;
Hilgenfeld, R
.
EMBO JOURNAL,
2002, 21 (13)
:3213-3224

Anand, K
论文数: 0 引用数: 0
h-index: 0
机构: Univ Wurzburg, Inst Immunol & Virol, D-97078 Wurzburg, Germany

Palm, GJ
论文数: 0 引用数: 0
h-index: 0
机构: Univ Wurzburg, Inst Immunol & Virol, D-97078 Wurzburg, Germany

Mesters, JR
论文数: 0 引用数: 0
h-index: 0
机构: Univ Wurzburg, Inst Immunol & Virol, D-97078 Wurzburg, Germany

Siddell, SG
论文数: 0 引用数: 0
h-index: 0
机构: Univ Wurzburg, Inst Immunol & Virol, D-97078 Wurzburg, Germany

Ziebuhr, J
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Wurzburg, Inst Immunol & Virol, D-97078 Wurzburg, Germany Univ Wurzburg, Inst Immunol & Virol, D-97078 Wurzburg, Germany

Hilgenfeld, R
论文数: 0 引用数: 0
h-index: 0
机构: Univ Wurzburg, Inst Immunol & Virol, D-97078 Wurzburg, Germany
[3]
MECHANISM OF ACTION OF CYSTEINE PROTEINASES - OXYANION BINDING-SITE IS NOT ESSENTIAL IN THE HYDROLYSIS OF SPECIFIC SUBSTRATES
[J].
ASBOTH, B
;
STOKUM, E
;
KHAN, IU
;
POLGAR, L
.
BIOCHEMISTRY,
1985, 24 (03)
:606-609

ASBOTH, B
论文数: 0 引用数: 0
h-index: 0
机构:
HUNGARIAN ACAD SCI,BIOL RES CTR,INST ENZYMOL,POB 7,H-1502 BUDAPEST,HUNGARY HUNGARIAN ACAD SCI,BIOL RES CTR,INST ENZYMOL,POB 7,H-1502 BUDAPEST,HUNGARY

STOKUM, E
论文数: 0 引用数: 0
h-index: 0
机构:
HUNGARIAN ACAD SCI,BIOL RES CTR,INST ENZYMOL,POB 7,H-1502 BUDAPEST,HUNGARY HUNGARIAN ACAD SCI,BIOL RES CTR,INST ENZYMOL,POB 7,H-1502 BUDAPEST,HUNGARY

KHAN, IU
论文数: 0 引用数: 0
h-index: 0
机构:
HUNGARIAN ACAD SCI,BIOL RES CTR,INST ENZYMOL,POB 7,H-1502 BUDAPEST,HUNGARY HUNGARIAN ACAD SCI,BIOL RES CTR,INST ENZYMOL,POB 7,H-1502 BUDAPEST,HUNGARY

POLGAR, L
论文数: 0 引用数: 0
h-index: 0
机构:
HUNGARIAN ACAD SCI,BIOL RES CTR,INST ENZYMOL,POB 7,H-1502 BUDAPEST,HUNGARY HUNGARIAN ACAD SCI,BIOL RES CTR,INST ENZYMOL,POB 7,H-1502 BUDAPEST,HUNGARY
[4]
The refined crystal structure of the 3C gene product from hepatitis A virus: Specific proteinase activity and RNA recognition
[J].
Bergmann, EM
;
Mosimann, SC
;
Chernaia, MM
;
Malcolm, BA
;
James, MNG
.
JOURNAL OF VIROLOGY,
1997, 71 (03)
:2436-2448

Bergmann, EM
论文数: 0 引用数: 0
h-index: 0
机构: UNIV ALBERTA, DEPT BIOCHEM, MED RES COUNCIL CANADA GRP PROT STRUCT & FUNCT, EDMONTON, AB T6G 2H7, CANADA

Mosimann, SC
论文数: 0 引用数: 0
h-index: 0
机构: UNIV ALBERTA, DEPT BIOCHEM, MED RES COUNCIL CANADA GRP PROT STRUCT & FUNCT, EDMONTON, AB T6G 2H7, CANADA

Chernaia, MM
论文数: 0 引用数: 0
h-index: 0
机构: UNIV ALBERTA, DEPT BIOCHEM, MED RES COUNCIL CANADA GRP PROT STRUCT & FUNCT, EDMONTON, AB T6G 2H7, CANADA

Malcolm, BA
论文数: 0 引用数: 0
h-index: 0
机构: UNIV ALBERTA, DEPT BIOCHEM, MED RES COUNCIL CANADA GRP PROT STRUCT & FUNCT, EDMONTON, AB T6G 2H7, CANADA

James, MNG
论文数: 0 引用数: 0
h-index: 0
机构: UNIV ALBERTA, DEPT BIOCHEM, MED RES COUNCIL CANADA GRP PROT STRUCT & FUNCT, EDMONTON, AB T6G 2H7, CANADA
[5]
THE INTERPLAY OF ELECTROSTATIC AND BINDING INTERACTIONS DETERMINING ACTIVE-CENTER CHEMISTRY AND CATALYTIC ACTIVITY IN ACTINIDIN AND PAPAIN
[J].
BROCKLEHURST, K
;
ODRISCOLL, M
;
KOWLESSUR, D
;
PHILLIPS, IR
;
TEMPLETON, W
;
THOMAS, EW
;
TOPHAM, CM
;
WHARTON, CW
.
BIOCHEMICAL JOURNAL,
1989, 257 (01)
:309-310

BROCKLEHURST, K
论文数: 0 引用数: 0
h-index: 0
机构: UNIV SALFORD,DEPT BIOL SCI,SALFORD M5 4WT,LANCS,ENGLAND

ODRISCOLL, M
论文数: 0 引用数: 0
h-index: 0
机构: UNIV SALFORD,DEPT BIOL SCI,SALFORD M5 4WT,LANCS,ENGLAND

KOWLESSUR, D
论文数: 0 引用数: 0
h-index: 0
机构: UNIV SALFORD,DEPT BIOL SCI,SALFORD M5 4WT,LANCS,ENGLAND

PHILLIPS, IR
论文数: 0 引用数: 0
h-index: 0
机构: UNIV SALFORD,DEPT BIOL SCI,SALFORD M5 4WT,LANCS,ENGLAND

TEMPLETON, W
论文数: 0 引用数: 0
h-index: 0
机构: UNIV SALFORD,DEPT BIOL SCI,SALFORD M5 4WT,LANCS,ENGLAND

THOMAS, EW
论文数: 0 引用数: 0
h-index: 0
机构: UNIV SALFORD,DEPT BIOL SCI,SALFORD M5 4WT,LANCS,ENGLAND

TOPHAM, CM
论文数: 0 引用数: 0
h-index: 0
机构: UNIV SALFORD,DEPT BIOL SCI,SALFORD M5 4WT,LANCS,ENGLAND

WHARTON, CW
论文数: 0 引用数: 0
h-index: 0
机构: UNIV SALFORD,DEPT BIOL SCI,SALFORD M5 4WT,LANCS,ENGLAND
[6]
Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS
[J].
Chou, KC
;
Wei, DQ
;
Zhong, WZ
.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
2003, 308 (01)
:148-151

Chou, KC
论文数: 0 引用数: 0
h-index: 0
机构: Gordon Life Sci Inst, Kalamazoo, MI 49009 USA

Wei, DQ
论文数: 0 引用数: 0
h-index: 0
机构: Gordon Life Sci Inst, Kalamazoo, MI 49009 USA

Zhong, WZ
论文数: 0 引用数: 0
h-index: 0
机构: Gordon Life Sci Inst, Kalamazoo, MI 49009 USA
[7]
Sortase from Staphylococcus aureus does not contain a thiolate-imidazolium ion pair in its active site
[J].
Connolly, KM
;
Smith, BT
;
Pilpa, R
;
Ilangovan, U
;
Jung, ME
;
Clubb, RT
.
JOURNAL OF BIOLOGICAL CHEMISTRY,
2003, 278 (36)
:34061-34065

Connolly, KM
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA

Smith, BT
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA

Pilpa, R
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA

Ilangovan, U
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA

Jung, ME
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA

Clubb, RT
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA
[8]
Electrostatic properties in the catalytic site of papain: A possible regulatory mechanism for the reactivity of the ion pair
[J].
Dardenne, LE
;
Werneck, AS
;
Neto, MD
;
Bisch, PM
.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS,
2003, 52 (02)
:236-253

Dardenne, LE
论文数: 0 引用数: 0
h-index: 0
机构: Univ Fed Rio de Janeiro, Lab Fis Biol, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, RJ, Brazil

Werneck, AS
论文数: 0 引用数: 0
h-index: 0
机构: Univ Fed Rio de Janeiro, Lab Fis Biol, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, RJ, Brazil

Neto, MD
论文数: 0 引用数: 0
h-index: 0
机构: Univ Fed Rio de Janeiro, Lab Fis Biol, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, RJ, Brazil

Bisch, PM
论文数: 0 引用数: 0
h-index: 0
机构: Univ Fed Rio de Janeiro, Lab Fis Biol, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, RJ, Brazil
[9]
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: Structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics
[J].
Dragovich, PS
;
Prins, TJ
;
Zhou, R
;
Johnson, TO
;
Brown, EL
;
Maldonado, FC
;
Fuhrman, SA
;
Zalman, LS
;
Patick, AK
;
Matthews, DA
;
Hou, XJ
;
Meador, JW
;
Ferre, RA
;
Worland, ST
.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,
2002, 12 (05)
:733-738

Dragovich, PS
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Prins, TJ
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Zhou, R
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Johnson, TO
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Brown, EL
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Maldonado, FC
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Fuhrman, SA
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Zalman, LS
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Patick, AK
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Matthews, DA
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Hou, XJ
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Meador, JW
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Ferre, RA
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Worland, ST
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA
[10]
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics
[J].
Dragovich, PS
;
Prins, TJ
;
Zhou, R
;
Brown, EL
;
Maldonado, FC
;
Fuhrman, SA
;
Zalman, LS
;
Tuntland, T
;
Lee, CA
;
Patick, AK
;
Matthews, DA
;
Hendrickson, TF
;
Kosa, MB
;
Liu, B
;
Batugo, MR
;
Gleeson, JPR
;
Sakata, SK
;
Chen, LJ
;
Guzman, MC
;
Meador, JW
;
Ferre, RA
;
Worland, ST
.
JOURNAL OF MEDICINAL CHEMISTRY,
2002, 45 (08)
:1607-1623

Dragovich, PS
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Prins, TJ
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Zhou, R
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Brown, EL
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Maldonado, FC
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Fuhrman, SA
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Zalman, LS
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Tuntland, T
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Lee, CA
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Patick, AK
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Matthews, DA
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Hendrickson, TF
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Kosa, MB
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Liu, B
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Batugo, MR
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Gleeson, JPR
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Sakata, SK
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Chen, LJ
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Guzman, MC
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Meador, JW
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Ferre, RA
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA

Worland, ST
论文数: 0 引用数: 0
h-index: 0
机构:
Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA Agouron Pharmaceut Inc, Pfizer Global Res & Dev La Jolla, San Diego, CA 92121 USA